Optimizing Treatment for ADHD

• Posted on CoachRudy
• in ADHD & Medication
• on February 16, 2023
• No Comments.

What may be on the horizon for the treatment of attention-deficit/hyperactivity disorder (ADHD)? Matthew Brams, MD, joined Psychiatric Times’ Mental Health Minute to share his insights into a new study of the triple-release formulation of dexmethylphenidate CTx-1301 for adults with ADHD.

Brams—the principal investigator—explains that this new formulation is associated with an extra 4 hours of efficacy, thus supporting adult patients throughout their active day without the need for multiple dosing or medications.

Read the full article